Cargando…

Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing

BACKGROUND: Heterozygous paired box6 (Pax6) mutations lead to abnormal glucose metabolism in mice older than 6 months as well as in human beings. Our previous study found that Pax6 deficiency caused down-expression of prohormone convertase 1/3 (Pcsk1), resulting in defective proinsulin processing. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Zhao, Yanxia, Tang, Na, Feng, Ruopeng, Yang, Xiaolong, Lu, Nicole, Wen, Jinhua, Li, Lingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467282/
https://www.ncbi.nlm.nih.gov/pubmed/23056534
http://dx.doi.org/10.1371/journal.pone.0046934
_version_ 1782245780455686144
author Liu, Ting
Zhao, Yanxia
Tang, Na
Feng, Ruopeng
Yang, Xiaolong
Lu, Nicole
Wen, Jinhua
Li, Lingsong
author_facet Liu, Ting
Zhao, Yanxia
Tang, Na
Feng, Ruopeng
Yang, Xiaolong
Lu, Nicole
Wen, Jinhua
Li, Lingsong
author_sort Liu, Ting
collection PubMed
description BACKGROUND: Heterozygous paired box6 (Pax6) mutations lead to abnormal glucose metabolism in mice older than 6 months as well as in human beings. Our previous study found that Pax6 deficiency caused down-expression of prohormone convertase 1/3 (Pcsk1), resulting in defective proinsulin processing. As a protein cleaving enzyme, in addition to its expression, the activity of PC1/3 is closely related to its function. We therefore hypothesize that Pax6 mutation alters the activity of PC1/3, which affects proinsulin processing. METHODOLOGY/PRINCIPAL FINDINGS: Using quantitative RT-PCR, western blot and enzyme assay, we found that PC1/3 C-terminal cleavage and its activity were compromised in Pax6 R266Stop mutant mice, and the expression of Pcsk1n, a potent inhibitor of PC1/3, was elevated by Pax6 deficiency in the mutant mice and MIN6 cells. We confirmed the effect of proSAAS, the protein encoded by Pcsk1n, on PC1/3 C-terminal cleavage and its activity by Pcsk1n RNAi in MIN6 cells. Furthermore, by luciferase-reporter analysis, chromatin immunoprecipitation, and electrophoretic mobility shift assay, we revealed that Pax6 bound to Pcsk1n promoter and directly down-regulated its expression. Finally, by co-transfecting Pax6 siRNA with Pcsk1n siRNA, we showed that Pax6 knock-down inhibited proinsulin processing and that this effect could be rescued by proSAAS down-regulation. These findings confirm that Pax6 regulates proinsulin processing partially through proSAAS-mediated PC1/3 processing and activity. CONCLUSIONS/SIGNIFICANCE: Collectively, the above experiments demonstrate that Pax6 can directly down-regulate Pcsk1n expression, which negatively affects PC1/3 C-terminal cleavage and activity and subsequently participates in proinsulin processing. We identified proSAAS as a novel down-regulated target of Pax6 in the regulation of glucose metabolism. This study also provides a complete molecular mechanism for the Pax6 deficiency-caused diabetes.
format Online
Article
Text
id pubmed-3467282
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34672822012-10-10 Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing Liu, Ting Zhao, Yanxia Tang, Na Feng, Ruopeng Yang, Xiaolong Lu, Nicole Wen, Jinhua Li, Lingsong PLoS One Research Article BACKGROUND: Heterozygous paired box6 (Pax6) mutations lead to abnormal glucose metabolism in mice older than 6 months as well as in human beings. Our previous study found that Pax6 deficiency caused down-expression of prohormone convertase 1/3 (Pcsk1), resulting in defective proinsulin processing. As a protein cleaving enzyme, in addition to its expression, the activity of PC1/3 is closely related to its function. We therefore hypothesize that Pax6 mutation alters the activity of PC1/3, which affects proinsulin processing. METHODOLOGY/PRINCIPAL FINDINGS: Using quantitative RT-PCR, western blot and enzyme assay, we found that PC1/3 C-terminal cleavage and its activity were compromised in Pax6 R266Stop mutant mice, and the expression of Pcsk1n, a potent inhibitor of PC1/3, was elevated by Pax6 deficiency in the mutant mice and MIN6 cells. We confirmed the effect of proSAAS, the protein encoded by Pcsk1n, on PC1/3 C-terminal cleavage and its activity by Pcsk1n RNAi in MIN6 cells. Furthermore, by luciferase-reporter analysis, chromatin immunoprecipitation, and electrophoretic mobility shift assay, we revealed that Pax6 bound to Pcsk1n promoter and directly down-regulated its expression. Finally, by co-transfecting Pax6 siRNA with Pcsk1n siRNA, we showed that Pax6 knock-down inhibited proinsulin processing and that this effect could be rescued by proSAAS down-regulation. These findings confirm that Pax6 regulates proinsulin processing partially through proSAAS-mediated PC1/3 processing and activity. CONCLUSIONS/SIGNIFICANCE: Collectively, the above experiments demonstrate that Pax6 can directly down-regulate Pcsk1n expression, which negatively affects PC1/3 C-terminal cleavage and activity and subsequently participates in proinsulin processing. We identified proSAAS as a novel down-regulated target of Pax6 in the regulation of glucose metabolism. This study also provides a complete molecular mechanism for the Pax6 deficiency-caused diabetes. Public Library of Science 2012-10-09 /pmc/articles/PMC3467282/ /pubmed/23056534 http://dx.doi.org/10.1371/journal.pone.0046934 Text en © 2012 Liu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Liu, Ting
Zhao, Yanxia
Tang, Na
Feng, Ruopeng
Yang, Xiaolong
Lu, Nicole
Wen, Jinhua
Li, Lingsong
Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title_full Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title_fullStr Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title_full_unstemmed Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title_short Pax6 Directly Down-Regulates Pcsk1n Expression Thereby Regulating PC1/3 Dependent Proinsulin Processing
title_sort pax6 directly down-regulates pcsk1n expression thereby regulating pc1/3 dependent proinsulin processing
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467282/
https://www.ncbi.nlm.nih.gov/pubmed/23056534
http://dx.doi.org/10.1371/journal.pone.0046934
work_keys_str_mv AT liuting pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT zhaoyanxia pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT tangna pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT fengruopeng pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT yangxiaolong pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT lunicole pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT wenjinhua pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing
AT lilingsong pax6directlydownregulatespcsk1nexpressiontherebyregulatingpc13dependentproinsulinprocessing